CellRapeutics™ TIL Therapy Development Solutions

Online Inquiry

All products and services are For Research Use Only and CANNOT be used in the treatment or diagnosis of disease.

Introduction

Tumor-infiltrating lymphocytes (TIL) therapy represents a groundbreaking advancement in treating of solid tumors, leveraging the body's immune system to target and eliminate cancerous cells. This therapy involves extracting TILs from a patient's tumor, expanding them ex vivo, and infusing them to fortify the body's natural defenses against malignancies. Recent breakthroughs underscore the therapy's potential to transform oncological care, with numerous studies reporting high response rates and prolonged overall survival across diverse tumor types.

TIL Therapy Development Solutions at Creative Biolabs

Creative Biolabs stands at the forefront of TIL therapy innovation, providing comprehensive and integrated solutions tailored to the nuanced demands of the field. With over two decades of industry expertise, Creative Biolabs has been instrumental in optimizing the therapeutic applications of TILs, driving their adoption as a feasible and efficacious cancer treatment modality. Our strategic focus on refining TIL extraction, cultivation, and infusion processes has empowered us to address the challenges of immunotherapy resistance, particularly in "cold" solid tumors that typically exhibit lower immunogenicity.

Fig.1 TIL therapy. (Arnaud, et al., 2023) Fig.1 Tumor-infiltrating lymphocyte (TIL) therapy.^1,3

Featured Services

One-Stop TIL Development

At Creative Biolabs, we pride ourselves on delivering One-Stop TIL Development services, a flagship offering designed to streamline the therapy development process. Our approach integrates tumor resection, TIL isolation, and expansion using state-of-the-art rapid expansion protocols (REP). These methodologies leverage cutting-edge monoclonal antibodies, feeder cell technology, and cytokine support to cultivate robust, patient-specific TILs. Each phase is meticulously optimized to ensure high-efficiency cell expansion while maintaining cellular phenotype and functionality, a critical determinant of therapeutic success.

Special TIL Therapy Development

In response to the dynamic landscape of cancer immunotherapy, Creative Biolabs offers specialized TIL Therapy Development services, catering to unique client requirements. Our offerings include advanced genetic engineering techniques to enhance TIL antitumor activity and resistance to immunosuppression. We also pioneer the development of neoantigen-reactive TILs, offering precision targeting for tumors with diverse neoantigen landscapes. By leveraging our proprietary platforms for molecular engineering, we optimize TIL gene expression, minimizing potential off-target effects and enhancing therapeutic indices.

Application Scenario of TIL Therapy Development

TIL therapy has demonstrated efficacy across multiple cancer types, including melanoma, cervical cancer, and certain challenging malignancies like non-small cell lung cancer and colorectal cancer. The flexibility of TIL therapy makes it adaptable to individual patient profiles, recognizing unique cancer neoantigens and overcoming tumor heterogeneity. Creative Biolabs' solutions extend to combining TIL therapy with immune checkpoint inhibitors, achieving synergistic effects that amplify anti-tumor responses and durable outcomes, thus broadening the application spectrum of TIL therapy.

Fig.2 TIL clinical trials treatment line and tumor types. (Wang, et al., 2021) Fig.2 Treatment line and tumor type analysis of TIL clinical trials.^2,3

Features of Our TIL Therapy Development Solutions

Creative Biolabs excels in the field due to its unwavering commitment to innovation and quality. Our solutions are characterized by:

Cutting-Edge Technology: We utilize the latest in genetic and cellular engineering to ensure TILs are highly potent and specifically targeted against cancer cells.
Safety and Efficacy: Emphasizing robust safety profiles, our TILs exhibit minimized toxicities and maximal therapeutic effects, supported by rigorous quality control processes.
Scalability: Our platforms are designed to support large-scale TIL cultivation, essential for delivering consistent therapeutic results across different patient demographics.

Frequently Asked Questions

Q1: What makes TIL therapy a promising treatment for solid tumors?

A1: TIL therapy leverages the body's immune cells to recognize and attack tumor cells, capitalizing on their natural specificity to cancer-associated antigens.

Q2: What advancements have been integrated into TIL development lately?

A2: Recent developments include the use of genetic modification techniques to enhance TIL cytotoxicity and resistance to tumor-suppressive environments.

What Customers Say

User 18***6

Partnering with Creative Biolabs has been transformative for our TIL therapy program. Their expertise in customized solutions, combined with a commitment to pioneering research, has been pivotal in advancing our therapeutic candidates through the development pipeline.

Creative Biolabs remains committed to driving forward the development of next-generation TIL therapies, with an enduring mission to revolutionize cancer treatment and improve patient outcomes worldwide.

References

Arnaud, Marion, George Coukos, and Alexandre Harari. "Towards next‐generation TIL therapy: TILs enriched in neoepitope‐specific T cells." Clinical and Translational Medicine 13.1 (2023).
Wang, Shuhang, et al. "Perspectives of tumor-infiltrating lymphocyte treatment in solid tumors." BMC medicine 19.1 (2021): 140.
Distributed under Open Access license CC BY 4.0, without modification.